2-Methyl-2-propanyl (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methyl-2-pyrrolidinyl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl) -1-pyrrolidinecarboxylate(CAS: 1378391-45-7)

The compound must comply with the REACH regulations for chemicals placed on the European market. It is also subject to the GHS classification for hazardous substances and requires FDA/EPA related requirements for its use in pharmaceuticals and pesticides. Specific safety data sheets (SDS) should be prepared to ensure compliance with local and international regulations.

Synthesis alternatives may include using 2-Methyl-2-propanol as a precursor, and substituting other amino acids or pyrrolidinyl derivatives for the valyl and pyrrolidinyl groups. These alternatives can vary in reactivity and yield, but they offer flexibility in chemical synthesis.

Research in this compound is primarily focused on its potential in pharmaceutical applications, particularly as an intermediate in drug synthesis. Market trends indicate increasing demand for specialized intermediates, driven by advancements in personalized medicine. However, due to its complexity, commercial availability is limited.

Waste containing this compound should be collected in sealed containers and disposed of through professional waste disposal services. Environmental protection measures should include minimizing the risk of leaks, and proper labeling of containers. Incineration or safe chemical degradation methods are preferred to prevent environmental contamination.